Guerbet

Guerbet: Q1 2025 revenue

24 4月 2025 11:45:00 条件 Nasdaq GlobeNewswire

GUERBET : 2024 full-year results.

26 3月 2025 12:45:00 条件 Nasdaq GlobeNewswire

DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan.

18 3月 2025 12:45:00 条件 Nasdaq GlobeNewswire

GUERBET : 2024 revenue.

06 2月 2025 11:45:00 条件 Nasdaq GlobeNewswire

GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF

03 2月 2025 06:00:00 条件 Nasdaq GlobeNewswire

Correction: GUERBET : Financial agenda for 2025

31 10月 2024 13:00:00 条件 Nasdaq GlobeNewswire

GUERBET : Revenue at September 30, 2024.

24 10月 2024 11:45:00 条件 Nasdaq GlobeNewswire

GUERBET : H1 2024 results.

25 9月 2024 11:45:00 条件 Nasdaq GlobeNewswire

GUERBET : H1 2024 revenue.

25 7月 2024 11:45:00 条件 Nasdaq GlobeNewswire

Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.

24 5月 2024 11:44:58 条件 Nasdaq GlobeNewswire

Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics.

22 5月 2024 11:45:00 条件 Nasdaq GlobeNewswire

Guerbet : Q1 2024 revenue.

25 4月 2024 11:45:00 条件 Nasdaq GlobeNewswire

Guerbet: Financial agenda for 2024

15 1月 2024 12:00:00 条件 Nasdaq GlobeNewswire

GUERBET : Revenue at 30 September 2023.

19 10月 2023 11:45:00 条件 Nasdaq GlobeNewswire

Guerbet: CHMP positive opinion

12 10月 2023 11:57:24 条件 Nasdaq GlobeNewswire

Guerbet: 2023 half-year results

20 9月 2023 11:45:00 条件 Nasdaq GlobeNewswire

Guerbet: First-half 2023 revenue

20 7月 2023 11:46:36 条件 Nasdaq GlobeNewswire

Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

17 7月 2023 13:00:19 条件 Nasdaq GlobeNewswire

Guerbet: Guerbet strengthens its Executive Committee with two new appointments to accelerate its commercial and industrial development

10 7月 2023 11:48:16 条件 Nasdaq GlobeNewswire

Guerbet: Changes in Guerbet's Board of Directors

26 5月 2023 11:29:04 条件 Nasdaq GlobeNewswire